Search

Author/Creator Stewart, Stephen

4. 358 Trial in progress: A pilot study of combined immune checkpoint inhibition in combination with ablative therapies in subjects with hepatocellular carcinoma (HCC). (9th November 2020)

Authors:
Carroll, Hailey; Aleem, Umair; Varghese, Pooja; Galligan, Marie; Bourke, Michèle; Hoey, Katherine; Ryan, Ronan; Doran, Peter; Stewart, Stephen; O'Farrelly, Cliona; Greten, Tim; Houlihan, Diarmaid; McDermott, Raymond; Duffy, Austin
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A383
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 358 Trial in progress: A pilot study of combined immune checkpoint inhibition in combination with ablative therapies in subjects with hepatocellular carcinoma (HCC). (10th December 2020)

Authors:
Carroll, Hailey; Aleem, Umair; Varghese, Pooja; Galligan, Marie; Bourke, Michèle; Hoey, Katherine; Ryan, Ronan; Doran, Peter; Stewart, Stephen; O'Farrelly, Cliona; Greten, Tim; Houlihan, Diarmaid; McDermott, Raymond; Duffy, Austin
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A218
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Variants in PCSK7, PNPLA3 and TM6SF2 are risk factors for the development of cirrhosis in hereditary haemochromatosis. Issue 7 (10th February 2021)

Authors:
Buch, Stephan; Sharma, Aneesh; Ryan, Eleanor; Datz, Christian; Griffiths, William J. H.; Way, Michael; Buckley, Thomas W. M.; Ryan, John D.; Stewart, Stephen; Wright, Callum; Dongiovanni, Paola; Fracanzani, Anna; Zwerina, Jochen; Merle, Uta; Weiss, Karl Heinz; Aigner, Elmar; Krones, Elisabeth; De...
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 53:Issue 7(2021)
Page Start:
830
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗